ICMR calls study on Covaxin side effects ‘poorly designed’

The Indian Council of Medical Research Director General, Dr Rajiv Bahl, criticised a recently published study on the long-term safety analysis of the Covaxin in adults and adolescents for its poor methodology and design, and clarified the article misleadingly and erroneously “acknowledges” ICMR.

Dr Bahl said the study



had no control arm of unvaccinated individuals for comparing the rates of events between the vaccinated and unvaccinated groups. Hence, the reported events in the study cannot be linked or attributed to Covid vaccination. The ICMR is not associated with the study and has not provided any financial or technical support for the research, Dr Bahl said.